Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma

Acta Oncol. 2006;45(5):627-9. doi: 10.1080/02841860500544909.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carcinoma, Neuroendocrine / diagnosis
  • Carcinoma, Neuroendocrine / drug therapy*
  • Carcinoma, Neuroendocrine / secondary
  • Disease Progression
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Mediastinal Neoplasms / diagnosis
  • Mediastinal Neoplasms / drug therapy*
  • Mediastinal Neoplasms / secondary
  • Middle Aged
  • Neoplasms, Unknown Primary / diagnosis
  • Neoplasms, Unknown Primary / drug therapy*
  • Octreotide / administration & dosage
  • Octreotide / analogs & derivatives*
  • Remission Induction
  • Risk Factors
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Etoposide
  • 90Y-octreotide, DOTA-Tyr(3)-
  • Carboplatin
  • Octreotide